Distinguishing Pathological & Healthy Neuronal Signatures on Brain-Derived Analytes in the Blood for Neurodegenerative Disease
Time: 1:30 pm
day: Blood-Based Biomarker Focus Day
Details:
- Concordance between CSF and blood-derived biomarkers
- Predictive power of fluid biomarkers
- Utility in patient selection and efficacy
- Exploring the latest insights from Phase 1 and ongoing Phase 2 data from a disease-modifying Parkinson’s Disease trial
